Terms: = Cervical cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
37 results:
1. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Breast cancer Complicated by Fibrous Dysplasia That Was Difficult to Differentiate from Bone Metastasis].
Makino Y; Otani A; Hikino H; Murata Y; Miura H; Harada A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1465-1467. PubMed ID: 38303309
[TBL] [Abstract] [Full Text] [Related]
3. Assessing the Genomic Landscape of cervical cancers: Clinical Opportunities and Therapeutic Targets.
Friedman CF; Ravichandran V; Miller K; Vanderbilt C; Zhou Q; Iasonos A; Vivek M; Mishra P; Leitao MM; Broach V; Sonoda Y; Kyi C; Zamarin D; O'Cearbhaill RE; Konner J; Berger MF; Weigelt B; Momeni Boroujeni A; Park KJ; Aghajanian C; Solit DB; Donoghue MTA
Clin Cancer Res; 2023 Nov; 29(22):4660-4668. PubMed ID: 37643132
[TBL] [Abstract] [Full Text] [Related]
4. The role of her2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.
Talia KL; Banet N; Buza N
Pathology; 2023 Feb; 55(1):8-18. PubMed ID: 36503635
[TBL] [Abstract] [Full Text] [Related]
5. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
Buza N
Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Long-Term Survival in a Patient with Advanced Gastric cancer with Virchow's Lymph Node Metastasis Which Received Multidisciplinary Treatment].
Hattori S; Wakabayashi K; Okazaki S; Taguchi K; Minoshima K; Suematsu Y; Takahashi M; Saito H; Fukahori M; Teranishi N; Ito Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1994-1996. PubMed ID: 33468778
[TBL] [Abstract] [Full Text] [Related]
8. Relationship Between CIP2A and Endometrium cancer.
Aslan F; Güney G; Avcıkurt AS; Taşkın MI; Akgün GA
J Coll Physicians Surg Pak; 2020 Apr; 30(4):373-378. PubMed ID: 32513355
[TBL] [Abstract] [Full Text] [Related]
9. Regular aspirin intake and prognosis of TxN2-3M0 nasopharyngeal carcinoma: A cohort study based on propensity score matching.
Chang H; Tao YL; Ye WJ; Xiao WW; Xia YF; Gao YH
Oral Oncol; 2020 Apr; 103():104589. PubMed ID: 32058295
[TBL] [Abstract] [Full Text] [Related]
10. Role and significance of her-2/neu as a biomarker in the premalignant and malignant lesions of uterine cervix.
Varshney S; Maheshwari V; Aijaz M; Alam K
Ann Diagn Pathol; 2020 Apr; 45():151443. PubMed ID: 31923745
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract] [Full Text] [Related]
12. Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.
Brown TJ; Sher DJ; Nedzi LA; Hughes RS; Beg MS; Mull J; Sarode VR; Khan SA
Head Neck; 2017 May; 39(5):E69-E71. PubMed ID: 28225558
[TBL] [Abstract] [Full Text] [Related]
13. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
[TBL] [Abstract] [Full Text] [Related]
14. Evaluating cytology for the detection of invasive cervical cancer.
Landy R; Castanon A; Hamilton W; Lim AW; Dudding N; Hollingworth A; Sasieni PD
Cytopathology; 2016 Jun; 27(3):201-9. PubMed ID: 26126636
[TBL] [Abstract] [Full Text] [Related]
15. [Prevalence of breast cancer sub-types by immunohistochemistry in patients in the Regional General Hospital 72, Instituto Mexicano del Seguro Social].
Pérez-Rodríguez G
Cir Cir; 2015; 83(3):193-8. PubMed ID: 26055281
[TBL] [Abstract] [Full Text] [Related]
16. [A case of hyoid bone metastasis from breast cancer].
Kusama H; Okishiro M; Ishida T; Sato Y; Morimoto Y; Matsushita K; Hashimoto T; Kimura K; Katsura Y; Nitta K; Kagawa Y; Takeno A; Sakisaka H; Nakahira S; Taniguchi K; Egawa C; Takeda Y; Kato T; Tamura S; Takatsuka Y; Oku K; Goto T; Nagano T; Nakatsuka S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1915-7. PubMed ID: 25731374
[TBL] [Abstract] [Full Text] [Related]
17. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.
Rambau P; Masalu N; Jackson K; Chalya P; Serra P; Bravaccini S
BMC Res Notes; 2014 Jun; 7():399. PubMed ID: 24964871
[TBL] [Abstract] [Full Text] [Related]
18. Predictors of cervical lymph node metastasis in salivary gland cancer.
Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
[TBL] [Abstract] [Full Text] [Related]
19. Endometrial stromal sarcoma arising from endometriosis: a clinicopathological study and literature review.
Lan C; Huang X; Lin S; Cai M; Liu J
Gynecol Obstet Invest; 2012; 74(4):288-97. PubMed ID: 22986788
[TBL] [Abstract] [Full Text] [Related]
20. her-2/neu expression in lesions of uterine cervix: is it reliable and consistent?
Gupta N; Singh S; Marwah N; Kumar S; Chabra S; Sen R
Indian J Pathol Microbiol; 2009; 52(4):482-5. PubMed ID: 19805951
[TBL] [Abstract] [Full Text] [Related]
[Next]
